0001171843-20-005951.txt : 20200814 0001171843-20-005951.hdr.sgml : 20200814 20200814161520 ACCESSION NUMBER: 0001171843-20-005951 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200814 FILED AS OF DATE: 20200814 DATE AS OF CHANGE: 20200814 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shameze Rampertab CENTRAL INDEX KEY: 0001721810 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38298 FILM NUMBER: 201105253 MAIL ADDRESS: STREET 1: C/O ZOMEDICA PHARMACEUTICALS CORP. STREET 2: 3928 VARSITY DRIVE CITY: ANN ARBOR STATE: MI ZIP: 48108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zomedica Pharmaceuticals Corp. CENTRAL INDEX KEY: 0001684144 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 PHOENIX DRIVE STREET 2: SUITE 180 CITY: ANN ARBOR STATE: MI ZIP: 48108 BUSINESS PHONE: (734) 369-2555 MAIL ADDRESS: STREET 1: 100 PHOENIX DRIVE STREET 2: SUITE 180 CITY: ANN ARBOR STATE: MI ZIP: 48108 4 1 ownership.xml X0306 4 2020-08-14 1 0001684144 Zomedica Pharmaceuticals Corp. ZOM 0001721810 Shameze Rampertab C/O ZOMEDICA PHARMACEUTICALS CORP. 100 PHOENIX DRIVE, SUITE 180 ANN ARBOR MI 48018 0 0 0 1 Former CFO and Director The reporting ceased to be a director effective August 6, 2020 and ceased to be an executive officer effective August 14, 2020. As a result, the reporting person is no longer subject to Section 16 in connection with his transactions in the equity securities of Zomedica Pharmaceuticals Corp. and therefore will no longer report any such transactions on Form 4 or Form 5. /s/ Shameze Rampertab 2020-08-14